Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
Provided By GlobeNewswire
Last update: May 7, 2024
CARLSBAD, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in a fireside chat at the 2024 RBC Capital Markets Healthcare Conference on Wednesday, May 15, 2024, at 11:30 a.m. ET in New York.
Read more at globenewswire.com
